Study of treatment effect of drug to focal bone infarction of knee

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001911

Enrollment

Unknown

Registered

2011-12-29

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

focal bone infarction of knee

Interventions

1:Intravenous infusion with safflower injection and salvia miltiorrhiza injection

2:Rest

Eligibility

Sex/Gender

All

Age

38 Years to 62 Years

Inclusion criteria

Inclusion criteria: 1. Suffered from the pain of knee and be diagnosed focal bone infarction clearly; 2. Have no incentive such as trauma; 3. Function of liver and renal is normal; 4. Agreed to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Have incentive such as trauma; 2. Have obvious osteoarthritis of knee; 3. Obvious liver or renal insufficiency.

Design outcomes

Primary

Measure	Time frame
Lysholm score of the knee;AKS score of the knee;	—

Countries

China

Contacts

Public ContactYang Liu

jointsurgery@163.com+86 13908399739

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026